Thoene JG, Oshima RG, Crawhall JC, Olson DL, Schneider JA (1976) Cystinosis
doi: 10.3389/fendo.2023.1089315 Received 04 November 2022 Accepted 09 May 2023 Published 26 May 2023 Volume 14 - 2023 Edited by Dipak Kumar Sahoo, Iowa State University, United States Reviewed by Isabel Castro-Piedras, Texas Tech University Health Sciences Center, United States
Dave Asprey, founder of Bulletproof and a prominent biohacker, has discussed 5-Amino-1MQ in combination with other peptides, highlighting "a lot of buzz about this peptide especially in combination with the 5-amino 1MQ."[28] He suggests it for biohackers seeking metabolic hacks without extreme diets
The result is a dual-mechanism research tool whose effects can in principle exceed those of either component alone in research models where multiple repair pathways contribute to the outcome